BioCentury
ARTICLE | Company News

AC Immune, Biogen deal

May 2, 2016 7:00 AM UTC

The companies signed a three-year deal to develop and validate PET tracers for alpha-synuclein ( SNCA) as an imaging biomarker for Parkinson’s disease (PD) and to identify and develop PET tracers to d...